ERBB2 and neoplasm: Several mechanisms of trastuzumab actions have been proposed including, inhibition of HER2 shedding, inhibition of PI3K/AKT pathway, antibody-dependent cellular cytotoxicity, and inhibition of tumor angiogenesis (Table 1).